We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Renowned psychiatrist Dr. Anish Shah, MD of Siyan Clinical, the North Bay's largest outpatient psychiatric treatment center, offers a successful and cost-effective modality for treatment of clinical depression, particularly in individuals.
Biogen has signed an exclusive option agreement to buy Japan-based biotechnology company TMS’ TMS-007 drug candidate being developed for the treatment of acute ischemic stroke (AIS).